Therapix Biosciences Ltd. (NASDAQ:TRPX) has seen 1,500,967 shares traded in the recent trading session. The company, currently valued at $8.79 Million, closed the recent trade at $0.624 per share which meant it lost -$0.09 on the day or -13.01% during that session. The TRPX stock price is -651.6% off its 52-week high price of $4.69 and 59.62% above the 52-week low of $0.252. If we look at the company’s 10-day average daily trading volume, we find that it stood at 889.23 Million shares traded. The 3-month trading volume is 2.79 Million shares.
The consensus among analysts is that Therapix Biosciences Ltd. (TRPX) is a Buy stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.
Therapix Biosciences Ltd. (NASDAQ:TRPX) trade information
Despite being -14.11% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Jun 26 when the TRPX stock price touched $0.798 or saw a rise of 22.29%. Year-to-date, Therapix Biosciences Ltd. shares have moved -44.44%, while the 5-day performance has seen it change -18.24%. Over the past 30 days, the shares of Therapix Biosciences Ltd. (NASDAQ:TRPX) have changed 24.02%. Short interest in the company has seen 187.88 Million shares shorted with days to cover at 67.34.
Therapix Biosciences Ltd. (TRPX) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest +0% while over the next 5 years, the company’s earnings are expected to increase by 0%.